Ro Telehealth Capital Cycle

This model turned telehealth into a software led commerce business, not a clinic business. Ro and Hims did not need to recruit, schedule, and carry large staffs of employed doctors in each market. They built the consumer app, routed each patient to a contracted clinician, then made the real money when that prescription converted into a recurring drug subscription, which let them scale much faster than provider heavy peers like Teladoc or clinic based models.

• In practice, the user filled out an intake form online, a clinician reviewed it asynchronously or by video, and the medication shipped directly to the home. That meant Ro could offer the visit for free, because the consult was customer acquisition for the higher margin pharmacy sale.
  1 sacra 2 sacra
• Using contractors also kept the operating model lighter than telehealth systems that employed clinicians directly. Kry is the clearest contrast. It built a more traditional care delivery org with 1,300 plus doctors and healthcare workers, which supports quality control and repeat care but is much harder to scale quickly.
  4 sacra 5 sacra
• The tradeoff was weaker retention and more commodity like economics. Erectile dysfunction and hair loss are easy to prescribe and easy to substitute, which helped Ro and Hims grow fast but also led to roughly 50 percent yearly churn and rising ad costs as copycats crowded the same Facebook and Google channels.
  1 sacra 3 sacra

The market has since moved toward conditions where the marketplace alone is not enough. Weight loss, hormones, fertility, and chronic care require labs, follow ups, dose changes, and tighter clinical control. That is why the winners are layering owned pharmacies, diagnostics, and care infrastructure on top of the original contractor marketplace, turning an asset light wedge into a more integrated healthcare stack.